Valuation: ResMed Inc.

Market Cap 31.88B 28.07B 26.6B 24.01B 45.26B 3,057B 45.84B 318B 122B 1,563B 120B 117B 5,010B P/E 2027 *
19.2x
P/E 2028 * 17.4x
Enterprise Value 30.92B 27.23B 25.8B 23.29B 43.9B 2,965B 44.47B 309B 119B 1,516B 116B 114B 4,860B EV / Sales 2027 *
5.33x
EV / Sales 2028 * 4.9x
Free-Float
75.13%
Yield 2027 *
1.19%
Yield 2028 * 1.32%
Current month-2.94%
1 month-1.98%
3 months+13.79%
6 months+4.76%
Current year-3.88%
1 week 19.8
Extreme 19.8
19.8
1 month 18.5
Extreme 18.5
20.4
3 years 13.1
Extreme 13.1
24.8
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-13.16%+37.50% 31.88B
+0.39%+2.60%+40.74%+37.69% 251B
-0.99%+0.79%+12.63%+4.48% 159B
-0.99%+2.58%-8.64%+38.51% 146B
-0.59%-2.02%-55.22%-17.21% 63.59B
-1.88%-0.29%+11.32%+25.14% 50.77B
-0.29%+5.58%+36.00%+57.39% 49.35B
-1.76%+2.07%-17.49%-21.01% 48.75B
+2.58%+5.62%-4.01%+42.15% 45.1B
+0.05%+5.86%+48.50%+64.58% 43.55B
Average -0.25%+2.89%+5.07%+26.92% 95.22B
Weighted average by Cap. -0.24%+3.06%+11.80%+26.65%

Financials

2027 *2028 *
Net sales 5.81B 5.11B 4.84B 4.37B 8.24B 557B 8.35B 57.96B 22.3B 285B 21.8B 21.33B 912B 6.17B 5.43B 5.15B 4.65B 8.76B 592B 8.87B 61.61B 23.71B 303B 23.17B 22.67B 970B
Net income 1.64B 1.45B 1.37B 1.24B 2.33B 157B 2.36B 16.39B 6.31B 80.49B 6.17B 6.03B 258B 1.78B 1.57B 1.49B 1.34B 2.53B 171B 2.56B 17.79B 6.85B 87.37B 6.69B 6.55B 280B
Net Debt -955M -841M -797M -719M -1.36B -91.54B -1.37B -9.53B -3.67B -46.8B -3.58B -3.51B -150B -1.61B -1.42B -1.35B -1.21B -2.29B -155B -2.32B -16.1B -6.2B -79.05B -6.06B -5.92B -253B
Logo ResMed Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
-
Date Price Change
30/09/26 €19.80 0.00%
29/09/26 €19.80 0.00%
28/09/26 €19.80 0.00%
25/09/26 €19.80 0.00%
24/09/26 €19.80 0.00%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
222.83USD
Average target price
250.22USD
Spread / Average Target
+12.29%

Quarterly revenue - Rate of surprise